Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J Sues Boehringer Unit Over Doxil Production Pact
Bloomberg
Friday, September 13, 2013 - 8:32am
tags:
JNJ, Boehringer Ingelheim, Doxil
ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1
Yahoo
Friday, September 13, 2013 - 8:30am
tags:
Dolutegravir, ViiV Healthcare, Darunavir, HIV-1, ING114915
Orphan drug status granted for GMI-1070 in Europe
Yahoo/Fly on the Wall
Friday, September 13, 2013 - 8:28am
tags:
GMI-1070, Europe, GlycoMimetics, sickle cell anemia
1 Drug Dramatically Reshaping Pancreatic Cancer Treatment
Motley Fool
Friday, September 13, 2013 - 8:27am
tags:
Celgene, pancreatic cancer, Abraxane
Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy
Seeking Alpha
Thursday, September 12, 2013 - 11:39am
tags:
Biodel, insulin, diabetes, BIOD-123
Pharma chief casts doubt on Roche interest in Alexion
Fierce Pharma
Thursday, September 12, 2013 - 10:30am
tags:
Alexion, Roche, M&A, Daniel O'Day
Glaxo’s Drug Approvals Boost Morale as China Probe Drags
Bloomberg
Thursday, September 12, 2013 - 10:27am
tags:
GSK, China, darapladib, MAGE-A3
Omeros' OMS824 shows positive Phase 1 results
Yahoo
Thursday, September 12, 2013 - 10:24am
tags:
Omeros, OMS824, Huntington's disease, schizophrenia
StemCells announce first transplant in phase 1,2 trial in AMD
Yahoo/Fly on the Wall
Thursday, September 12, 2013 - 10:23am
tags:
StemCells, dry AMD, stem cells
3 Compelling Oncology Biotechs From Rodman & Renshaw 2013
Seeking Alpha
Thursday, September 12, 2013 - 10:22am
tags:
oncology, Rodman & Renshaw, CytRx, Sorrento Therapeutics, Champions Oncology
Celgene's And Osiris' IP Positions Weakened By Pluristem's Pivotal Patent
Seeking Alpha
Thursday, September 12, 2013 - 10:20am
tags:
Celegene, Osiris, stem cells, Pluristem, patents, placental-based cells
Why Sangamo Was Smart To Buy Ceregene
TheStreet.com
Thursday, September 12, 2013 - 10:19am
tags:
Sangamo, Ceregene, M&A
Hospira all set to launch Remicade biosimilar in Europe
Pharma Times, UK
Thursday, September 12, 2013 - 10:16am
tags:
Hospira, biosimilars, Remicade, Europe, JNJ, Merck
Biotech Indicators Rose Last Year, But So Did Losses: Survey
Pharmalot
Thursday, September 12, 2013 - 10:10am
tags:
biotech
Does This Orphan Leukemia Treatment Have Blockbuster Potential?
Motley Fool
Thursday, September 12, 2013 - 10:02am
tags:
Iclusig, Ariad Pharmaceuticals, chronic myeloid leukemia
Vical's Herpes Vaccine: An Update
Seeking Alpha
Thursday, September 12, 2013 - 9:32am
tags:
vaccines, Vical, Allovectin, herpes simplex 2
Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics
Yahoo
Thursday, September 12, 2013 - 9:28am
tags:
Cubist Pharmaceuticals, Trius Therapeutics
Elite Pharmaceuticals: Call It A Comeback Story
Seeking Alpha
Thursday, September 12, 2013 - 9:25am
tags:
Elite Pharmaceuticals, Actavis
FDA approves Botox Cosmetic to improve the appearance of crow’s feet
Yahoo/Fly on the Wall
Thursday, September 12, 2013 - 9:23am
tags:
Allergan, crow's feet, FDA, Botox
Bristol-Myers skin cancer drug Yervoy misses goal in study of additional, prostate cancer use
Yahoo/AP
Thursday, September 12, 2013 - 9:21am
tags:
prostate cancer, Yervoy, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.